Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gregory

Showing results (801-810 of 1,034) with videos related to

Pageof 104
Sort By:
American Journal of Respiratory Cell and Molecular Biology|September 23, 2006
Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in miceJames G Karras, Jeffrey R Crosby, Mausumee Guha, et al.
Nature Materials|May 21, 2021
Quantifying charge carrier localization in chemically doped semiconducting polymersShawn A Gregory, Riley Hanus, Amalie Atassi, et al.
British Journal of Cancer|November 8, 2007
A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategiesN Lee, A J Smolarz, S Olson, et al.
Genes|February 1, 2019
H3K9 Promotes Under-Replication of Pericentromeric Heterochromatin in Drosophila Salivary Gland Polytene ChromosomesRobin L Armstrong, Taylor J R Penke, Samuel K Chao, et al.
Nature Reviews. Clinical Oncology|August 13, 2014
Vessel caliber--a potential MRI biomarker of tumour response in clinical trialsKyrre E Emblem, Christian T Farrar, Elizabeth R Gerstner, et al.
Journal of Colloid and Interface Science|June 29, 2021
Cell guidance on peptide micropatterned silk fibroin scaffoldsWeizhen Sun, Caroline S Taylor, Yi Zhang, et al.
Nature Cell Biology|April 1, 2008
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1Philip A Gregory, Andrew G Bert, Emily L Paterson, et al.
Scientific Reports|January 13, 2025
Antisense mediated blockade of Dickkopf 1 attenuates tumor survival, metastases and bone damage in experimental osteosarcomaAndrew Haskell, Simin Pan, Robert Reese, et al.
Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Journal of Biomedical Materials Research. Part A|October 15, 2024
Biocompatibility and Bone Regeneration by Shape Memory Polymer ScaffoldsShelby B Gasson, Lauren K Dobson, Michaela R Pfau-Cloud, et al.
Pageof 104

Showing results (801-810 of 1,034) with videos related to

Sort By:
Pageof 104
American Journal of Respiratory Cell and Molecular Biology|September 23, 2006
Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in miceJames G Karras, Jeffrey R Crosby, Mausumee Guha, et al.
Nature Materials|May 21, 2021
Quantifying charge carrier localization in chemically doped semiconducting polymersShawn A Gregory, Riley Hanus, Amalie Atassi, et al.
British Journal of Cancer|November 8, 2007
A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategiesN Lee, A J Smolarz, S Olson, et al.
Genes|February 1, 2019
H3K9 Promotes Under-Replication of Pericentromeric Heterochromatin in Drosophila Salivary Gland Polytene ChromosomesRobin L Armstrong, Taylor J R Penke, Samuel K Chao, et al.
Nature Reviews. Clinical Oncology|August 13, 2014
Vessel caliber--a potential MRI biomarker of tumour response in clinical trialsKyrre E Emblem, Christian T Farrar, Elizabeth R Gerstner, et al.
Journal of Colloid and Interface Science|June 29, 2021
Cell guidance on peptide micropatterned silk fibroin scaffoldsWeizhen Sun, Caroline S Taylor, Yi Zhang, et al.
Nature Cell Biology|April 1, 2008
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1Philip A Gregory, Andrew G Bert, Emily L Paterson, et al.
Scientific Reports|January 13, 2025
Antisense mediated blockade of Dickkopf 1 attenuates tumor survival, metastases and bone damage in experimental osteosarcomaAndrew Haskell, Simin Pan, Robert Reese, et al.
Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Journal of Biomedical Materials Research. Part A|October 15, 2024
Biocompatibility and Bone Regeneration by Shape Memory Polymer ScaffoldsShelby B Gasson, Lauren K Dobson, Michaela R Pfau-Cloud, et al.
Pageof 104